Top compounds associated with response to CC2D2B


Feature Type Standardized
Nominal ANOVA
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA WP1130 CTRPv2 pan-cancer AAC -0.037 0.3
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.035 0.3
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.3
mRNA BRD-K84807411 CTRPv2 pan-cancer AAC -0.076 0.3
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.037 0.3
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.3
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
mRNA palmostatin B CTRPv2 pan-cancer AAC -0.045 0.3
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.035 0.3
Download CSV